##plugins.themes.academic_pro.article.sidebar##

Download
pdf
Statistic
Read Counter : 193 Download : 92

##plugins.themes.academic_pro.article.main##

Abstract

Staphylococcus aureus is one of the world's most frequent pathogens that responsible for a wide range of infectious diseases. As plasminogen is converted into the active fibrinolytic enzyme, plasmin by staphylokinase, a staphylococcal protein Staphylokinase is also produced by S. aureus bacteria that infect people. Antibiotic-resistant bacteria are blocked from invading tissues by Sak achieve's capacity to form complexes of plasminogen activating complexes with plasmin as well as with plasmin. As a result of staphylokinase's tiny size, it also acts as an immunomodulator that is represented by an increase in IL-10 blood level (an anti-inflammatory cytokine) and a decrease in IL-4 serum level, which is associated with a reduction in the development of hypersensitivity. Both beneficial and detrimental effects can be achieved by immunomodulation. Immunomodulators abruptly modify informational molecules, like as cytokines, to affect the immune system's activity. If streptokinase is administered regularly, it can cause allergic reactions and the formation of anti-streptokinase antibodies

Keywords

Staphylococcus staphylokinase immunomodulation

##plugins.themes.academic_pro.article.details##

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite
Malaa M. Taki, Mohammed H.Dawood, Mona Adel Ismail, & Noor Hadi Hassan. (2022). Immunoregulatory activity of Staphylokinase produced by Staphylococcus aureus. Texas Journal of Multidisciplinary Studies, 11, 82–86. Retrieved from https://zienjournals.com/index.php/tjm/article/view/2266

References

  1. Akdis, M., Aab, A., Altunbulakli, C., Azkur, K., Costa, R. A., Crameri, R., Kovacs N., Sokolowska M. & Frei, R. (2016). Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF- α: Receptors, functions, and roles in diseases. Journal of Allergy and
  2. Banerjee A, Chisti Y, Banerjee UC.(2003). Streptokinase—a clinically useful thrombolytic agent. Biotechnol Advances ; 22: 287-307.
  3. Bascones-Martinez, A., Mattila, R., Gomez-Font, R., & Meurman, J. H. (2014). Immunomodulatory drugs: Oral and systemic adverse effects. Medicina oral, patologia oral y cirugia bucal; 19(1), e24.
  4. Bhurani, V., & Dalai, S. K. (2018). Therapeutic Potentials of IL- 10 versus IL-12. Immunoregulatory Aspects of Immunotherapy, 89(9): 629–641.
  5. Bien, J.; Sokolova , O. and Bozko, P. (2011). Characterization of Virulence Factors of Staphylococcus aureus: Novel Function of Known Virulence Factors That Are Implicated in Activation of Airway Epithelial Pro inflammatory Response .Journal of Pathogens; 7(9): 629–641.
  6. Brockmann, L., Soukou, S., Steglich, B., Czarnewski, P., Zhao, L., Wende, S., & Geffken, M. (2018). Molecular and functional heterogeneity of IL-10-producing CD4+ T cells. Naturecommunications;9(1), 1-14.
  7. Clinical Immunology; 138(4), 984-1010.
  8. communications; 8(1): 1-7.
  9. David, H. (2014). Management of Staphylococcus aureus-infected atopic eczema. International Journal of Clinical Nursing; 28(4):79-82.
  10. Devriese L. A. and Kerckhove A. (1980) A comparison of methods used for testing staphylokinase(fibrinolysin) production in Staphylococcus strains. Journal of Experimental Medicine;206(1), 69-78.
  11. Frank J Carr. (2017). Microbiology: A Fundamental Introduction Second Edition‖. EC Microbiology; 8.3: 123-183.
  12. Gnanamani, A., Hariharan, P., & Paul-Satyaseela, M. (2017). Staphylococcus aureus: Overview of bacteriology, clinical diseases, epidemiology, antibiotic resistance and therapeutic approach. Frontiers in Staphylococcus aureus; 4-28.
  13. Hadi R. R. Al-Taai .(2017). Molecular detection of erm(A), mef(A) in Staphylococcus spp. and Streptococcus spp resistant to macrolide from different clinical infections. Diyala Journal of Agricultural Sciences; 9(Special Issue): 1-15, 2017.
  14. Kapur, S., & Pal, A. (2018). Immune cell activation: stimulation, costimulation, and regulation of cellular activation. In Immune Response Activation and Immunomodulation. IntechOpen; 37(3), e13-e21.
  15. Kattula, S., Byrnes, J. R., & Wolberg, A. S. (2017). Fibrinogen and fibrin in hemostasis and thrombosis. Arteriosclerosis, thrombosis, and vascular biology; 37(3), e13-e21.
  16. Khan, M. F. (2017). Brief history of Staphylococcus aureus: a focus to antibiotic resistance. EC Microbiology; 5 (2): 36-39.
  17. Lehrer, R. I., & Lu, W. (2012). α‐Defensins in human innate immunity. Immunological reviews; 245(1): 84-112.
  18. Liang, Y., Chen, X., Chen, J., & Liu, F. (2018). Differentiation and Function of T Cell Subsets in Infectious Diseases. Journal of immunology research 245(1): 84-112.
  19. Mangino, M., Roederer, M., Beddall, M. H., Nestle, F. O., & Spector, T. D. (2017). Innate and adaptive immune traits are differentially affected by genetic and environmental factors. Nature
  20. Marijke Peetermans Vanassche, T., Liesenborghs, L., Claes, J., Velde, G. V., Kwiecinksi, J., & Verhamme, P. (2014). Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections. BMC microbiology; 14(1): 1-12.
  21. Marijke Peetermans Vanassche, T., Liesenborghs, L., Claes, J., Velde, G. V., Kwiecinksi, J., & Verhamme, P. (2014). Plasminogen activation by staphylokinase enhances local spreading of S. aureus in skin infections. BMC microbiology; 14(1): 1-12.
  22. Nguyen, T. H., Park, M. D., & Otto, M. (2017). Host response to Staphylococcus epidermidis colonization and infections. Frontiers in cellular and infection microbiology; 7, 90: 593-600.
  23. Reddy, P. N., Srirama, K., & Dirisala, V. R. (2017). An update on clinical burden, diagnostic tools, and therapeutic options of Staphylococcus aureus. Infectious Diseases: Research and Treatment; 10.
  24. Reinhart, R., & Kaufmann, T. (2018). IL-4 enhances survival of in vitro-differentiated mouse basophils through transcription-independent signaling downstream of PI3K. Cell death & disease; 9(7): 1-12
  25. Rother, J., Ford, G. A., & Thijs, V. N. (2013). Thrombolytics in acute ischaemic stroke: historical perspective and future opportunities. Cerebrovascular Diseases; 35(4): 313-319.
  26. Saunders, S. P., Ma, E. G., Aranda, C. J., & Curotto de Lafaille, M. A. (2019). Non-classical B cell memory of allergic IgE responses. Frontiers in immunology; 10, 715.
  27. Silence, K., Hartmann, M., Gührs, K. H., Gase, A., Schlott, B., Collen, D., & Lijnen, H. R. (1995). Structure-function relationships in staphylokinase as revealed by" clustered charge to alanine" mutagenesis. Journal of Biological Chemistry; 270(45):27192-27198
  28. Sumera, A., Chaudhury, P., Haque, S., Saha, P., Paul, D., & Jawed, A. (2018). Staphylokinase: A Potent Thrombolytic Agent. International Journal of Engineering Science Invention (IJESI); 7 (1): 2319 – 6734.
  29. Tam, K., & Torres, V. J. (2019). Staphylococcus aureus secreted toxins and extracellular enzymes. Gram‐Positive Pathogens, 640-668.
  30. Taylor, T. A., and Unakal, C. G. (2019). Staphylococcus aureus. In StatPearls [Internet]. StatPearls Publishing PMID: 28722898.
  31. Wang, S. B., Deng, Y. Q., Ren, J., Xiao, B. K., Liu, Z., & Tao, Z. Z. (2014). Exogenous interleukin-10 alleviates allergic inflammation but inhibits local interleukin-10 expression in a mouse allergic rhinitis model. BMC immunology; 15(1), 9.